CLASS II Device recall · Reported 6 Feb 2013 · FDA Enforcement Report

BBL(TM) Fildes Enrichment recalled by Becton Dickinson &

Becton Dickinson & is recalling BBL(TM) Fildes Enrichment, distributed nationwide in the US. The recall was initiated on 10 Dec 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot/Exp 2079066/ EXP March 6, 2013 2096375/ EXP March 22, 2013 2216092/ EXP July 20, 2013 2227271/ EXP Auqust 2, 2013
Quantity recalled11,710 tubes

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0739-2013
FDA event ID
64008
Recalling firm
Becton Dickinson &, Sparks, MD
Classification
Class II
Status
Terminated
Recall initiated
10 Dec 2012
FDA classified
25 Jan 2013
Reported
6 Feb 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

10 Dec 2012Recall initiated by company
25 Jan 2013Classified by FDA+46 days
6 Feb 2013Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Enrichment media intended to enhance the cultivation of various microorganisms may fail to support the growth of Haemophilus species.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

BBL(TM) Fildes Enrichment, catalog number 211866, 10 tubes/pack, labeled in part ***Becton Dickinson and Company, Sparks, MD 21152 USA*** Intended Use: Fildes Enrichment may be used to enrich a variety of media for the cultivation of various microorganisms. Fildes Enrichment is a peptic digest of sheep blood used to enhance the growth of fastidious organisms. It may be added to Tryptic/Trypticase Soy Broth or Agar in final concentration of 5% for cultivation of Haemophilus influenzae. Fildes Enrichment is intended to be a rich source of growth factors stimulatory to various microorganisms, including the X (hemin) and V (nicotinamide adenine dinucleotide, NAD) factors necessary for the growth of Haemophilus influenzae. Labeling: For Laboratory Use.

Where it was distributed

Worldwide Distribution - USA (nationwide) and internationally to Australia, Belgium, Canada, South Korea, Taiwan, Hong Kong, Japan, Mexico, and Singapore.

Nationwide

Questions about this recall

Is BBL(TM) Fildes Enrichment recalled?

Yes. Becton Dickinson & recalled BBL(TM) Fildes Enrichment on 10 Dec 2012. The recall is Class II and its status is Terminated. Recall number Z-0739-2013.

Why was it recalled?

Enrichment media intended to enhance the cultivation of various microorganisms may fail to support the growth of Haemophilus species.

Which lots are affected?

Lot/Exp 2079066/ EXP March 6, 2013 2096375/ EXP March 22, 2013 2216092/ EXP July 20, 2013 2227271/ EXP Auqust 2, 2013

Where was it sold?

Worldwide Distribution - USA (nationwide) and internationally to Australia, Belgium, Canada, South Korea, Taiwan, Hong Kong, Japan, Mexico, and Singapore.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Other Medical Devices recalls

All 13,778